Single Blind, Randomized, Controlled Trial of Conventional Versus Split-Dose Bowel Preparation for Inpatient Colonoscopy
Phase 4
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Gastrointestinal Hemorrhage, Colon Cancer, Diverticulosis
Both
Gastrointestinal Hemorrhage, Colon Cancer, Diverticulosis
Trial Information
Single Blind, Randomized, Controlled Trial of Conventional Versus Split-Dose Bowel Preparation for Inpatient Colonoscopy
Inclusion Criteria:
- any diagnosis for which colonoscopy is indicated
Exclusion Criteria:
- ileus
- severe colitis/toxic megacolon
- gastric retention
- bowel perforation
- gastrointestinal obstruction
- gastroparesis that precludes oral bowel preparation
- pregnant or lactating women
- allergy to polyethylene glycol.
- unable to give consent
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Diagnostic
Outcome Measure:
Quality of colon cleansing
Outcome Time Frame:
24 hours from study enrollment
Safety Issue:
No
Authority:
United States: Institutional Review Board
Study ID:
10-041
NCT ID:
NCT01169220
Start Date:
July 2010
Completion Date:
July 2012
Related Keywords:
- Gastrointestinal Hemorrhage
- Colon Cancer
- Diverticulosis
- Colonoscopy
- Bowel preparation
- Colonic Neoplasms
- Diverticulum
- Gastrointestinal Hemorrhage
- Hemorrhage
Name | Location |
|---|---|
| Santa Clara Valley Medical Center | San Jose, California 95128 |
